Let's see will MSDI run again today. The company is merging with Innovate Biopharmaceuticals that has the only drug to treat Celiac Disease of the digestive system. They're release their phase III clinical study after merging with Monster Digital, Inc. Sound like a winner for Monster Digital shareholders (MSDI). keeping this one.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.